Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
Clinical trial NCT00568984 · COMPLETED
Trial details
- NCT number
- NCT00568984
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-21
- Primary completion
- 2003-11-10
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.